• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外筛选用于治疗与系统性疾病相关的口腔病原体感染的 和益生菌菌株。

In Vitro Selection of and Probiotic Strains for the Management of Oral Pathobiont Infections Associated to Systemic Diseases.

机构信息

Laboratory of Applied Microbiology, Department of Health Sciences (DiSS), Center for Translational Research on Allergic and Autoimmune Diseases (CAAD), School of Medicine, Università del Piemonte Orientale (UPO), Corso Trieste 15/A, 28100 Novara, Italy.

Clinical Chemistry Unit, DiSS, School of Medicine, University Hospital "Maggiore della Carità", Università del Piemonte Orientale (UPO), Corso Mazzini 18, 28100 Novara, Italy.

出版信息

Int J Mol Sci. 2022 Dec 18;23(24):16163. doi: 10.3390/ijms232416163.

DOI:10.3390/ijms232416163
PMID:36555802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9787750/
Abstract

The human oral pathobionts , and , in dysbiosis-promoting conditions, lead to oral infections, which also represent a threat to human systemic health. This scenario may be worsened by antibiotic misuse, which favours multi-drug resistance, making the research on pathogen containment strategies more than crucial. Therefore, we aimed to in vitro select the most promising probiotic strains against oral pathogen growth, viability, biofilm formation, and co-aggregation capacity, employing both the viable probiotics and their cell-free supernatants (CFSs). Interestingly, we also assessed probiotic efficacy against the three-pathogen co-culture, mimicking an environment similar to that in vivo. Overall, the results showed that CFSs performed better than the , highlighting LRE11, LR04, LC04, and LF26 as the most effective strains, opening the chance to deeper investigation of their action and CFS composition. Altogether, the methodologies presented in this study can be used for probiotic efficacy screenings, in order to better focus the research on a viable probiotic, or on its postbiotics, suitable in case of infections.

摘要

人类口腔共生菌在促进失调的条件下,会导致口腔感染,这也对人类全身健康构成威胁。这种情况可能因抗生素滥用而恶化,抗生素滥用有利于多重耐药性的产生,这使得研究病原体控制策略变得至关重要。因此,我们旨在体外选择最有前途的益生菌菌株,以抑制口腔病原体的生长、活力、生物膜形成和共聚能力,同时使用活菌和其无细胞上清液(CFS)。有趣的是,我们还评估了益生菌对三病原体共培养的功效,模拟体内类似的环境。总的来说,结果表明 CFS 比活菌表现更好,突出了 LRE11、LR04、LC04 和 LF26 作为最有效的菌株,为进一步研究它们的作用和 CFS 组成开辟了机会。总之,本研究中提出的方法可用于益生菌功效筛选,以便更好地将研究重点放在有活力的益生菌或其后生元上,以便在感染时使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/78455298eb35/ijms-23-16163-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/fd4ae3842c74/ijms-23-16163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/a3fd95b33e07/ijms-23-16163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/45d701db3268/ijms-23-16163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/9ccd2f78bb4d/ijms-23-16163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/f4f76260e594/ijms-23-16163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/78455298eb35/ijms-23-16163-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/fd4ae3842c74/ijms-23-16163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/a3fd95b33e07/ijms-23-16163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/45d701db3268/ijms-23-16163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/9ccd2f78bb4d/ijms-23-16163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/f4f76260e594/ijms-23-16163-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2799/9787750/78455298eb35/ijms-23-16163-g006.jpg

相似文献

1
In Vitro Selection of and Probiotic Strains for the Management of Oral Pathobiont Infections Associated to Systemic Diseases.体外筛选用于治疗与系统性疾病相关的口腔病原体感染的 和益生菌菌株。
Int J Mol Sci. 2022 Dec 18;23(24):16163. doi: 10.3390/ijms232416163.
2
The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans.五种益生菌乳酸杆菌菌株对变形链球菌生长和生物膜形成的影响。
Oral Dis. 2015 Jan;21(1):e128-34. doi: 10.1111/odi.12257. Epub 2014 Jun 3.
3
Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.益生菌乳杆菌体外干扰变异链球菌生物膜的形成。
Curr Microbiol. 2011 Feb;62(2):618-22. doi: 10.1007/s00284-010-9752-9. Epub 2010 Sep 11.
4
Antibacterial activity of viable and heat-killed probiotic strains against oral pathogens.益生菌活菌和热死菌对口腔病原菌的抗菌活性。
Lett Appl Microbiol. 2020 Apr;70(4):310-317. doi: 10.1111/lam.13275. Epub 2020 Feb 11.
5
Exploring the In Vitro Antibacterial Potential of Specific Probiotic Strains against Oral Pathogens.探索特定益生菌菌株对口腔病原菌的体外抗菌潜力。
Microorganisms. 2024 Feb 21;12(3):441. doi: 10.3390/microorganisms12030441.
6
Viability of probiotic (Bifidobacterium, Lactobacillus acidophilus and Lactobacillus casei) and nonprobiotic microflora in Argentinian Fresco cheese.阿根廷弗雷斯可奶酪中益生菌(双歧杆菌、嗜酸乳杆菌和干酪乳杆菌)及非益生菌微生物区系的生存能力。
J Dairy Sci. 2000 Sep;83(9):1905-11. doi: 10.3168/jds.s0022-0302(00)75065-x.
7
Antimicrobial activity of Bifidobacterium spp. isolated from healthy adult Koreans against cariogenic microflora.从健康成年韩国人分离的双歧杆菌对致龋微生物的抗菌活性。
Arch Oral Biol. 2011 Oct;56(10):1047-54. doi: 10.1016/j.archoralbio.2011.03.002. Epub 2011 Mar 25.
8
Supportive Role of Probiotic Strains in Protecting Rats from Ovariectomy-Induced Cortical Bone Loss.益生菌菌株在保护大鼠免受卵巢切除诱导的皮质骨丢失中的支持作用。
Probiotics Antimicrob Proteins. 2019 Dec;11(4):1145-1154. doi: 10.1007/s12602-018-9443-6.
9
Selective and differential enumerations of Lactobacillus delbrueckii subsp. bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium spp. in yoghurt--a review.发酵乳中德氏乳杆菌保加利亚亚种、嗜热链球菌、嗜酸乳杆菌、干酪乳杆菌和双歧杆菌属的选择性和差异计数——综述。
Int J Food Microbiol. 2011 Oct 3;149(3):194-208. doi: 10.1016/j.ijfoodmicro.2011.07.008. Epub 2011 Jul 21.
10
Inhibition of Streptococcus mutans Biofilm Formation by the Joint Action of Oxyresveratrol and Lactobacillus casei.氧麦角固醇与干酪乳杆菌联合抑制变形链球菌生物膜形成。
Appl Environ Microbiol. 2022 May 10;88(9):e0243621. doi: 10.1128/aem.02436-21. Epub 2022 Apr 13.

引用本文的文献

1
Development of Chitosan-Polyacrylic Acid Complex Systems for Enhanced Oral Delivery of and Probiotics.用于增强和益生菌口服递送的壳聚糖-聚丙烯酸复合体系的开发。
Drug Des Devel Ther. 2025 Jan 25;19:585-598. doi: 10.2147/DDDT.S478925. eCollection 2025.
2
Effects of L9 on Oral Microbiota and Cariogenic Factors in -Infected Mice.L9对感染小鼠口腔微生物群和致龋因素的影响。
Foods. 2024 Dec 19;13(24):4118. doi: 10.3390/foods13244118.
3
Evaluating the health risk of probiotic supplements from the perspective of antimicrobial resistance.

本文引用的文献

1
Infective endocarditis by HACEK: a review.HACEK 感染性心内膜炎:综述。
J Cardiothorac Surg. 2022 Aug 19;17(1):185. doi: 10.1186/s13019-022-01932-5.
2
An animal derivative-free medium enhances Lactobacillus johnsonii LJO02 supernatant selective efficacy against the methicillin (oxacillin)-resistant Staphylococcus aureus virulence through key-metabolites.无动物源培养基通过关键代谢产物增强了约氏乳杆菌 LJO02 上清液对耐甲氧西林(苯唑西林)金黄色葡萄球菌毒力的选择性。
Sci Rep. 2022 May 23;12(1):8666. doi: 10.1038/s41598-022-12718-z.
3
Cancer and Infective Endocarditis: Characteristics and Prognostic Impact.
从抗菌药物耐药性的角度评估益生菌补充剂的健康风险。
Microbiol Spectr. 2025 Jan 7;13(1):e0001924. doi: 10.1128/spectrum.00019-24. Epub 2024 Dec 10.
4
Prebiotics and Probiotics: Healthy Biotools for Molecular Integrative and Modulation Approaches.益生元和益生菌:分子综合与调节方法的健康生物工具。
Int J Mol Sci. 2023 Apr 20;24(8):7559. doi: 10.3390/ijms24087559.
5
Growth Conditions Influence Cell-Free Supernatant Impact on Viability, Biofilm Formation, and Co-Aggregation of the Oral Periodontopathogens and .生长条件影响无细胞上清液对口腔牙周病原体和的活力、生物膜形成及共聚集的作用。
Biomedicines. 2023 Mar 11;11(3):859. doi: 10.3390/biomedicines11030859.
癌症与感染性心内膜炎:特征及对预后的影响
Front Cardiovasc Med. 2021 Nov 11;8:766996. doi: 10.3389/fcvm.2021.766996. eCollection 2021.
4
Antimicrobial activity of probiotics against oral pathogens around orthodontic mini-implants: an in vitro study.益生菌对正畸微型种植体周围口腔病原体的抗菌活性:一项体外研究。
Dental Press J Orthod. 2021 Oct 15;26(5):e2119350. doi: 10.1590/2177-6709.26.5.e2119350.oar. eCollection 2021.
5
Interactions between probiotic and oral pathogenic strains.益生菌与口腔致病菌株之间的相互作用。
Biol Futur. 2021 Dec;72(4):461-471. doi: 10.1007/s42977-021-00091-3. Epub 2021 Jun 2.
6
Inhibitory effects of Lactobacillus brevis KU15153 against Streptococcus mutans KCTC 5316 causing dental caries.短乳杆菌KU15153对致龋变形链球菌KCTC 5316的抑制作用。
Microb Pathog. 2021 Aug;157:104938. doi: 10.1016/j.micpath.2021.104938. Epub 2021 May 20.
7
Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens.乳酸菌无细胞上清液对多药耐药泌尿生殖道病原体的抗菌特性。
Microbiologyopen. 2021 Feb;10(2):e1173. doi: 10.1002/mbo3.1173.
8
Oral Pathogen Coaggregates With to Modulate the Inflammatory Cytotoxicity of Pulmonary Epithelial Cells.口腔病原体与……共聚集以调节肺上皮细胞的炎性细胞毒性。 (原句中“Coaggregates With to”表述有误,推测可能是“Coaggregates With...”)
Front Cell Infect Microbiol. 2021 Mar 19;11:643913. doi: 10.3389/fcimb.2021.643913. eCollection 2021.
9
Microbiota in Gut, Oral Cavity, and Mitral Valves Are Associated With Rheumatic Heart Disease.肠道、口腔和二尖瓣中的微生物群与风湿性心脏病有关。
Front Cell Infect Microbiol. 2021 Mar 9;11:643092. doi: 10.3389/fcimb.2021.643092. eCollection 2021.
10
A concerted probiotic activity to inhibit periodontitis-associated bacteria.协同益生菌活性抑制牙周炎相关细菌。
PLoS One. 2021 Mar 5;16(3):e0248308. doi: 10.1371/journal.pone.0248308. eCollection 2021.